Clinicopathologic Analysis of Breast Cancers with PIK3CA Mutations in Japanese Women

作者: Naomi Maruyama , Yasuo Miyoshi , Tetsuya Taguchi , Yasuhiro Tamaki , Morito Monden

DOI: 10.1158/1078-0432.CCR-06-0267

关键词: Progesterone Receptor StatusCancer researchLymph nodeApocrineMissense mutationMutationPathologyEstrogen receptorBiologyBreast cancerImmunohistochemistryOncology

摘要: Purpose: Somatic mutations of PIK3CA , which encodes the p110α catalytic subunit phosphatidylinositol 3-kinase, have recently been shown to play an important role in pathogenesis and progression human breast cancers. In this study, frequency their relationship with clinicopathologic biological variables were investigated Japanese Experimental Design: Mutational analysis was done 188 primary cancers women. Relationship these various [histologic type, tumor size, histologic grade, lymph node status, estrogen receptor (ER)-α progesterone prognosis], [phospho-AKT (pAKT) HER2 expression determined by immunohistochemistry], p53 mutation status studied. Results: Missense found 44 158 invasive ductal carcinomas, 4 10 lobular 1 mucinous 2 squamous apocrine but no 12 noninvasive carcinomas. -mutated tumors be more likely ER-α positive ( P status. significantly a significant Conclusions: The is similar that Caucasian Association pAKT suggests might exert effects through activation 3-kinase/AKT/ER-α pathway. seem potential used as indicator favorable prognosis.

参考文章(40)
Aye Aye Thant, Akihiro Nawa, Fumitaka Kikkawa, Yasukatu Ichigotani, Yangying Zhang, Thet Thet Sein, A.R.M. Ruhul Amin, Michinari Hamaguchi, Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells. Clinical & Experimental Metastasis. ,vol. 18, pp. 423- 428 ,(2000) , 10.1023/A:1010921730952
Guojun Wu, Mingzhao Xing, Elizabeth Mambo, Xin Huang, Junwei Liu, Zhongmin Guo, Aditi Chatterjee, David Goldenberg, Susanne M Gollin, Saraswati Sukumar, Barry Trink, David Sidransky, Somatic mutation and gain of copy number of PIK3CA in human breast cancer. Breast Cancer Research. ,vol. 7, pp. 1- 8 ,(2005) , 10.1186/BCR1262
Vivian Li, Chi Wong, Tsun Chan, Agnes Chan, Wei Zhao, Kent-Man Chu, Samuel So, Xin Chen, Siu Yuen, Suet Leung, None, Mutations of PIK3CA in gastric adenocarcinoma. BMC Cancer. ,vol. 5, pp. 29- 29 ,(2005) , 10.1186/1471-2407-5-29
Jill E Kucab, Cathy Lee, Ching-Shih Chen, Jiuxiang Zhu, C Blake Gilks, Maggie Cheang, David Huntsman, Erika Yorida, Joanne Emerman, Michael Pollak, Sandra E Dunn, Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours. Breast Cancer Research. ,vol. 7, pp. 1- 12 ,(2005) , 10.1186/BCR1294
Jennet M. Harvey, Gary M. Clark, C. Kent Osborne, D. Craig Allred, Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer Journal of Clinical Oncology. ,vol. 17, pp. 1474- 1474 ,(1999) , 10.1200/JCO.1999.17.5.1474
Tove Kirkegaard, Caroline J Witton, Liane M McGlynn, Sian M Tovey, Barbara Dunne, Alison Lyon, John MS Bartlett, AKT activation predicts outcome in breast cancer patients treated with tamoxifen. The Journal of Pathology. ,vol. 207, pp. 139- 146 ,(2005) , 10.1002/PATH.1829
Douglas A. Levine, Faina Bogomolniy, Cindy J. Yee, Alex Lash, Richard R. Barakat, Patrick I. Borgen, Jeff Boyd, Frequent Mutation of the PIK3CA Gene in Ovarian and Breast Cancers Clinical Cancer Research. ,vol. 11, pp. 2875- 2878 ,(2005) , 10.1158/1078-0432.CCR-04-2142
Fiamma Buttitta, Lara Felicioni, Fabio Barassi, Carla Martella, Diego Paolizzi, Giuseppina Fresu, Simona Salvatore, Franco Cuccurullo, Andrea Mezzetti, Daniela Campani, Antonio Marchetti, PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma. The Journal of Pathology. ,vol. 208, pp. 350- 355 ,(2006) , 10.1002/PATH.1908